Interventions intended to help pregnant women lose weight may not prevent large-for-gestational-age (LGA) newborns, a study of 2618 women has found.
Interventions intended to help pregnant women lose weight may not prevent large-for-gestational-age (LGA) newborns, a study of 2618 women has found.
Researchers at the UCD Centre for Human Reproduction at Coombe Women and Infants University Hospital in Dublin, Ireland, recruited nondiabetic women after ultrasound confirmation of an ongoing singleton pregnancy in the first trimester. They hoped to estimate whether maternal fat mass measured in the first trimester correlated better with birth weight than did fat-free mass, and to identify which maternal body composition parameters correlated best with birth weight.
Maternal body composition was measured using bioelectric impedance analysis. Multivariable linear regression analysis was performed to identify the strongest predictors of birth weight, with multiple logistic regression analysis performed to assess predictors of birth weight greater than 4 kg (8 lb 13.09 oz).
Of the 2618 women, 49.6% (n=1075) were primigravid and 16.5% (n=432) were obese based on a body mass index (BMI) of 30 or higher. In univariable analysis, maternal age, BMI, parity, gestational age at delivery, smoking, fat mass, and fat-free mass all correlated significantly with birth weight. In multivariable regression analysis, fat-free mass remained a significant predictor of birth weight (P<.001), but notably, no relationship was found between maternal fat mass and birth weight, the researchers reported. After adjustment for confounding variables, women in the highest fat-free mass quartile had an adjusted odds ratio of 3.64 (95% confidence interval 2.34–5.68) for a birth weight more than 4 kg compared with those in the lowest quartile.
In an article published in the January 2013 issue of Obstetrics & Gynecology, the researchers conclude, “there is a potential risk that overzealous attempts to reduce gestational weight gain in obese women may cause complications by reducing calorie intake or micronutrients. This reduction may be detrimental to the fetus and, in the absence of gestational diabetes mellitus, our results suggest minimizing maternal weight gain may not prevent fetal macrosomia and could potentially increase the risk of intrauterine growth restriction.”
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Link between reproductive life span and postmenopausal muscle mass
November 30th 2023A recent study in Menopause, the journal of The Menopause Society, suggests that a longer reproductive life span and later age at menopause may be associated with a reduced risk of low handgrip strength in postmenopausal women.
Read More
How physicians can boost COVID-19 vaccine uptake among Spanish-speaking pregnant individuals
November 29th 2023Discover the crucial findings from a recent study investigating vaccine decision-making among Spanish-speaking pregnant individuals, highlighting the pivotal role doctors play in dispelling vaccine hesitancy and fostering acceptance through targeted information dissemination and culturally sensitive approaches.
Read More
NIDA study reports surge in pregnancy-associated drug overdose deaths
November 29th 2023Researchers from the National Institute on Drug Abuse unveil a 3-fold spike in drug overdose deaths among pregnant women aged 10 to 44 years between 2018 and 2021, highlighting pervasive barriers like discrimination and stigma hindering access to life-saving treatment.
Read More